Kidney Research and Clinical Practice

Pharmacologic therapeutics in sarcopenia with chronic kidney disease: Ran-hui Cha; Kidney Res Clin Pract. 2024;43(2):143-155. Published online February 19, 2024; DOI: https://doi.org/10.23876/j.krcp.23.094; Full text PubReader ePub PDF

Efficacy of intradialytic neuromuscular electrical stimulation and oral nutritional supplementation in hemodialysis patients: a multicenter, randomized controlled trial: Jae Hyeon Park, Jae Yoon Park, Geum Sil Lee, Ran-hui Cha; Received June 2, 2023 Accepted October 2, 2023 Published online February 7, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Performance evaluation of Chronic Kidney Disease Epidemiology Collaboration equations for estimated glomerular filtration rate compared to inulin clearance in Koreans: Jeong Min Cho, Ran-hui Cha, Dong Ki Kim, Ho Jun Chin; Received May 17, 2023 Accepted September 12, 2023 Published online February 7, 2024; [Epub ahead of print]
Cited By 1; Full text PubReader ePub PDF Supplementary Material

Factors associated with gait speed: results from the RolE of AST120 (Renamezin) in sarCOpenia preVEntion in pRe-dialYsis chronic kidney disease patients (RECOVERY) study: Miyeun Han, Sang Heon Song, Su Hyun Kim et al.; Received July 6, 2022 Accepted December 25, 2022 Published online July 10, 2023; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey: Ran-hui Cha, Su Hyun Kim, Eun Hui Bae et al.; Kidney Res Clin Pract. 2019;38(3):373-381. Published online September 30, 2019; DOI: https://doi.org/10.23876/j.krcp.19.007
Web of Science 4 Cited By 4; Full text PubReader PDF Supplementary Material

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea [Volume 36, Issue 1, March 2017, Pag: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2018;37(1):98-99. Published online March 31, 2018; DOI: https://doi.org/10.23876/j.krcp.2018.37.1.98; Full text PubReader PDF

Physician perceptions of blood pressure control in patients with chronic kidney disease and target blood pressure achievement rate: Ran-hui Cha, Hajeong Lee, Jung Pyo Lee, Young Rim Song, Sung Gyun Kim, Yon Su Kim; Kidney Res Clin Pract. 2017;36(4):349-357. Published online December 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.4.349
Web of Science 4 Cited By 4; Full text PubReader PDF

Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea: Ran-hui Cha, Shin Wook Kang, Cheol Whee Park et al.; Kidney Res Clin Pract. 2017;36(1):68-78. Published online March 31, 2017; DOI: https://doi.org/10.23876/j.krcp.2017.36.1.68
Web of Science 33 Cited By 31; Full text PubReader PDF Supplementary Material

A rare case of hyperoxaluria presenting with acute liver injury and stone-free kidney injury: Si-eun Kim, Seon-Jae Kim, Seong Taek Chu, Seung Hee Yang, Yon Su Kim, Ran-hui Cha; Kidney Res Clin Pract. 2015;34(2):113-116. Published online March 27, 2015; DOI: https://doi.org/10.1016/j.krcp.2014.09.006
Web of Science 3 Cited By 5; Full text PubReader PDF

14,573	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
19,515	C4d Puzzle in ABO-incompatible kidney transplantation
7,923	How should we treat acute kidney injury caused by renal congestion?
12,737	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
34,814	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 14	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Search